AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Opglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Opsiscare Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Opglim M 1mg/500mg Tablet SR

Diabetics using the sustained-release Opglim M 1mg/500mg tablet, an anti-diabetic medication, manage type 2 diabetes through this dual-medicine formulation. It effectively regulates blood glucose. Consistent daily intake, ideally with meals, at the same time maximizes efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation risks elevated glucose levels and potential complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Commonly, Opglim M 1mg/500mg can cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Consistent mealtimes and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, are recommended by your physician.

Primary Ingredients of Opglim M 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Opglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Opglim M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Opglim M 1mg/500mg Extended-Release tablets should be administered with a meal.

Common Side effects of Opglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Opglim M 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Opglim M 1mg/500mg Tablet SR with a meal.

How Opglim M 1mg/500mg Tablet SR works:

Opglim M SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Opglim M 1mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Opglim M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Opglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Opglim M 1mg/500mg SR tablets, potentially requiring dosage modification. Physician consultation is recommended. Opglim M 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Opglim M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, a low initial dose of Opglim M 1mg/500mg Tablet SR is typical; however, it's contraindicated in cases of severe liver disease.

What if you forget to take Opglim M 1mg/500mg Tablet SR :

Should you forget to take your Opglim M 1mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Opglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Opglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Opglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Opglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Opglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Opglim M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Opglim M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Opglim M 1mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a readily available sugar source, such as glucose tablets, honey, or fruit juice.
Combining Opglim M 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Opglim M 1mg/500mg Tablet...
31
MRP 38
18% off